凝血障碍对内出血结果的影响:一项病例对照研究
Tzak Ying Lau1, Omar Alwakaa1, Aryan Wadhwa1
1Neurosurgical Service, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Neurosurgical review
|August 10, 2025
概括
凝血障碍显著影响内出血 (ICH) 患者的结果. 维生素K缺乏和血小板狭窄与高死亡率和更长的住院时间有关.
科学领域:
- 神经学 神经学
- 血液学 血液学 血液学
- 关键护理医学 关键护理医学
背景情况:
- 内出血 (ICH) 是一种严重的疾病,患病率和死亡率很高.
- 凝血障碍,包括血栓性,血栓性,血友性和维生素K缺乏,是影响ICH患者出血的重要因素.
研究的目的:
- 研究特定凝血障碍对ICH患者住院死亡率和住院时间 (LOS) 的影响.
- 根据存在维生素K缺乏,血小板缩,血栓友爱,血友爱和·维勒布兰德病的情况分析结果.
主要方法:
- 从全国住院患者样本 (NIS) 数据库 (2011-2020年) 中对260,049例ICH住院病人的回顾性分析.
- 根据特定的凝血障碍对患者进行了分类.
- 使用病例控制匹配来调整诸如年龄,性别,种族和并发症等混变量.
主要成果:
- 整体ICH死亡率为21.9%.
- 维生素K缺乏 (40.5%),原发性血栓性 (30.8%) 和·维勒布兰德病 (32.1%) 的死亡率较高.
- 维生素K缺乏和血友病与最长的LOS有关 (分别为17.6±23.9和14.1±18.1天).
- 病例控制匹配证实了基于凝血障碍类型的死亡率和LOS的显著差异.
结论:
- 凝血障碍在确定ICH结果方面发挥着至关重要的作用.
- 维生素K缺乏和血小板减少与特别严重的结果有关,包括增加死亡率和长时间住院.
- 早期识别和针对这些疾病的针对性干预对于改善ICH患者预后至关重要.
相关概念视频
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
903
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
903
01:09Coagulation
7.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.4K